Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04768556
Other study ID # RC31/20/0252
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 17, 2021
Est. completion date December 2024

Study information

Verified date May 2024
Source University Hospital, Toulouse
Contact Jeremie PARIENTE, MD PHD
Phone 05.61.77.95.02
Email pariente.j@chu-toulouse.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Inhibitory control allows individuals to suppress unwanted actions and to resist irrelevant stimuli. It is thought to be a core deficit in Attention-deficit/hyperactivity disorder (ADHD). The present study aims at evaluating this deficit in adults with ADHD. Executive and inhibitory capacities, as well as the neural mechanisms underlying inhibitory control, will be assessed in adults with ADHD and two control groups of participants.


Description:

ADHD is a psychiatric disorder characterized by symptoms of inattention, hyperactivity, and impulsivity (DSM-V, 2013). An impairment of inhibitory control has been suggested as the primary deficit in children with ADHD, which is thought to cause secondary impairments in executive functioning. A few studies investigated executive capacities in adults with ADHD. Specifically, an impairment in action inhibition has been reported in ADHD participants. Moreover, inhibition of action is often associated with distinctive electroencephalographic (EEG) correlates. The present study aim at combining both novel inhibitory control measurement techniques and EEG analysis in temporal and frequency domains to assess the sensitivity and the specificity of an inhibitory deficit in adults with ADHD. This is part of an improvement in the procedures for diagnosing ADHD syndrome and its functional evaluation. The study will analyze the EEG activity associated with two stop-signal tasks requiring inhibitory capacities. A set of other cognitive skills will also be evaluated during a neuropsychological assessment. The results of ADHD patients will be compared with those of a control group (healthy volunteers) to assess the sensitivity of an inhibition deficit to the disorder. These same results will also be compared with those of a second control group (patients with a negative diagnosis of ADHD) to assess the specificity of the inhibitory deficit. This experimental strategy results in the involvement of three groups of participants (ADHD patients and two control groups) in three visits (neuropsychological assessment and two EEG sessions).


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Age between 18 and 50, - Visual, auditory (authorized apparatus), motor skills suitable for the proper realization of neuropsychological tests, - Being right-handed, - Free, informed and written consent signed by the participant and the investigator - Person affiliated or beneficiary of a social security scheme. - For the ADHD group: - Diagnosis of ADHD according to DSM-V criteria (APA, 2013), For the patient control group: • Patient who consulted for a cognitive complaint and for whom the diagnosis of ADHD was rejected according to the criteria of DSM-V (APA, 2013). Exclusion Criteria: - General or progressive neurological disease resulting in cognitive impairment (multiple sclerosis, Parkinson's disease, stroke, etc.), - Insufficient linguistic level in French to participate in neuropsychological assessment, - Patient placed under judicial protection or under another protective regime, - Severe depression according to DSM-V criteria (APA, 2013), - Autism spectrum disorder, developmental coordination disorder. -For the healthy voluntary control group: - Presence of a cognitive complaint or pathology which may impair his cognitive functions

Study Design


Related Conditions & MeSH terms


Intervention

Other:
EEG experimental sessions 1
An EEG experimentation session on the stop-signal task of inhibiting a prepared discrete graphic action.
EEG experimental sessions 2
An EEG experimentation session on the stop-signal task of inhibiting an ongoing rhythmic action

Locations

Country Name City State
France Toulouse Purpan University Hospital Toulouse

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Toulouse Centre National de la Recherche Scientifique, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary EEG correlates of inhibition The main objective of this study is to evaluate, by electrophysiological measures, the presence of a deficit of action inhibition in adults with ADHD. To this end, the EEG correlates of inhibition will be compared between participants in the three groups. Thus, the ERP (N2 / P3) and ERSP (Theta, Delta) variations observed in terms of amplitude and latency in the stop-signal task tests will be computed in each of the three groups. 2 weeks
Secondary Inhibition performance from a rhythmic-action task The inhibition performance from a rhythmic-action task, expressed as stop-signal reaction time (SSRT, in ms). This latency is measured by identifying a statistical deviation evoked by the STOP signal in the participants' movement on a graphic tablet (following the procedure described in Hervault et al., 2019). 2 weeks
Secondary Inhibition performance from a discrete-action task The inhibition performance from a discrete-action task, expressed as an SSRT (in ms). According to the horse-race model of inhibition, this latency is estimated based on the response time and the response probability obtained by the participants when responding to the GO and STOP stimuli used in the task (following recent guidelines from Verbruggen et al., 2019). 2 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04275895 - Cognitive and Postural Activities of Prematurely Born Children N/A
Completed NCT03490110 - Brain Markers of Improvements in Cognitive Functioning N/A
Recruiting NCT03963661 - Investigating Usability of c-SIGHT in the Homes of Brain Injury Survivors N/A
Completed NCT05302362 - Effect of Fixed vs. Tailored Intensity tDCS for Attention Deficit After TBI N/A
Completed NCT05391698 - A Multimodal Intervention Program for Children With Attention Deficits (Child ViReal Support Program) N/A
Recruiting NCT04831762 - Markers of Executive Attention Development in Preschoolers - Behavioral Measures in Various Populations
Terminated NCT05219370 - Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD Phase 2
Withdrawn NCT05273918 - Monitoring and Evaluation of a Cognitive Behavioral Therapy Program Focused on Attention and Emotion Regulation for Children With Fetal Alcohol Spectrum Disorder N/A
Completed NCT02655276 - Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children N/A
Recruiting NCT02544295 - Based-virtual Reality Diagnosis for Neuropsychiatric Diseases and Sleep/Wake Disorders N/A
Recruiting NCT05802680 - Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation N/A
Completed NCT03318302 - Sleep and Exposure to Screens of Digital Media Devices in Israel N/A
Completed NCT04188626 - Identification of Biomarkers to Predict Driver Take-over Control Quality N/A
Recruiting NCT05099874 - Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease N/A
Enrolling by invitation NCT05831839 - Computerized Training of Attention and Working Memory in Post COVID-19 Patients With Cognitive Complaints N/A
Not yet recruiting NCT03271788 - Can Stroke Patients and Their Caregiver Benefit From Additive Mindfulness Training N/A